Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

RedHill Biopharma (RDHL) Gross Profit: 2014-2024

Historic Gross Profit for RedHill Biopharma (RDHL) over the last 10 years, with Dec 2024 value amounting to $4.9 million.

  • RedHill Biopharma's Gross Profit fell 89.41% to $990,000 in Q2 2023 from the same period last year, while for Jun 2023 it was $15.3 million, marking a year-over-year decrease of 51.16%. This contributed to the annual value of $4.9 million for FY2024, which is 57.96% up from last year.
  • According to the latest figures from FY2024, RedHill Biopharma's Gross Profit is $4.9 million, which was up 57.96% from $3.1 million recorded in FY2023.
  • In the past 5 years, RedHill Biopharma's Gross Profit registered a high of $36.4 million during FY2021, and its lowest value of $3.1 million during FY2023.
  • In the last 3 years, RedHill Biopharma's Gross Profit had a median value of $4.9 million in 2024 and averaged $12.1 million.
  • Per our database at Business Quant, RedHill Biopharma's Gross Profit surged by 581.23% in 2020 and then slumped by 89.21% in 2023.
  • RedHill Biopharma's Gross Profit (Yearly) stood at $27.5 million in 2020, then surged by 32.34% to $36.4 million in 2021, then fell by 21.70% to $28.5 million in 2022, then crashed by 89.21% to $3.1 million in 2023, then spiked by 57.96% to $4.9 million in 2024.